Patients with transverse myelitis who developed venous thromboembolism while hospitalized have increased rate for inpatient mortality

Samuel Maiser; Malik M. Adil; Pezhman Roohani; Nauman Tariq

doi:10.1016/j.jneuroim.2013.05.005

Patients with transverse myelitis who developed venous thromboembolism while hospitalized have increased rate for inpatient mortality

Samuel Maiser, Malik M. Adil, Pezhman Roohani, Nauman Tariq

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

The rate of venous thromboembolism (VTE) in patients with transverse myelitis (TM) is not known. Using the National Inpatient Sample database (NIS), from 2006-2010, the rate of VTE in TM patients was 1.3%, which included patients with both deep vein thrombosis (DVT) and pulmonary embolism (PE). The in-hospital mortality was higher in this group compared to TM patients without DVT and PE (11% and 0.5% respectively), and after adjusting for age, sex, presence of DVT and/or PE (odds ratio [OR], 21; 95% CI (2.2-207.0); p<. 0.008). The data supports the prompt initiation of VTE prophylaxis in patients hospitalized with TM.

Original language	English (US)
Pages (from-to)	120-122
Number of pages	3
Journal	Journal of Neuroimmunology
Volume	261
Issue number	1-2
DOIs	https://doi.org/10.1016/j.jneuroim.2013.05.005
State	Published - Aug 15 2013
Externally published	Yes

Keywords

Deep venous thrombosis
Pulmonary embolism
Transverse myelitis

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Neurology
Clinical Neurology

Access to Document

10.1016/j.jneuroim.2013.05.005

Cite this

@article{ee7a3a66dca444a8a257f07186340e65,

title = "Patients with transverse myelitis who developed venous thromboembolism while hospitalized have increased rate for inpatient mortality",

abstract = "The rate of venous thromboembolism (VTE) in patients with transverse myelitis (TM) is not known. Using the National Inpatient Sample database (NIS), from 2006-2010, the rate of VTE in TM patients was 1.3%, which included patients with both deep vein thrombosis (DVT) and pulmonary embolism (PE). The in-hospital mortality was higher in this group compared to TM patients without DVT and PE (11% and 0.5% respectively), and after adjusting for age, sex, presence of DVT and/or PE (odds ratio [OR], 21; 95% CI (2.2-207.0); p<. 0.008). The data supports the prompt initiation of VTE prophylaxis in patients hospitalized with TM.",

keywords = "Deep venous thrombosis, Pulmonary embolism, Transverse myelitis",

author = "Samuel Maiser and Adil, {Malik M.} and Pezhman Roohani and Nauman Tariq",

year = "2013",

month = aug,

day = "15",

doi = "10.1016/j.jneuroim.2013.05.005",

language = "English (US)",

volume = "261",

pages = "120--122",

journal = "Advances in Neuroimmunology",

issn = "0165-5728",

publisher = "Elsevier",

number = "1-2",

}

TY - JOUR

T1 - Patients with transverse myelitis who developed venous thromboembolism while hospitalized have increased rate for inpatient mortality

AU - Maiser, Samuel

AU - Adil, Malik M.

AU - Roohani, Pezhman

AU - Tariq, Nauman

PY - 2013/8/15

Y1 - 2013/8/15

N2 - The rate of venous thromboembolism (VTE) in patients with transverse myelitis (TM) is not known. Using the National Inpatient Sample database (NIS), from 2006-2010, the rate of VTE in TM patients was 1.3%, which included patients with both deep vein thrombosis (DVT) and pulmonary embolism (PE). The in-hospital mortality was higher in this group compared to TM patients without DVT and PE (11% and 0.5% respectively), and after adjusting for age, sex, presence of DVT and/or PE (odds ratio [OR], 21; 95% CI (2.2-207.0); p<. 0.008). The data supports the prompt initiation of VTE prophylaxis in patients hospitalized with TM.

AB - The rate of venous thromboembolism (VTE) in patients with transverse myelitis (TM) is not known. Using the National Inpatient Sample database (NIS), from 2006-2010, the rate of VTE in TM patients was 1.3%, which included patients with both deep vein thrombosis (DVT) and pulmonary embolism (PE). The in-hospital mortality was higher in this group compared to TM patients without DVT and PE (11% and 0.5% respectively), and after adjusting for age, sex, presence of DVT and/or PE (odds ratio [OR], 21; 95% CI (2.2-207.0); p<. 0.008). The data supports the prompt initiation of VTE prophylaxis in patients hospitalized with TM.

KW - Deep venous thrombosis

KW - Pulmonary embolism

KW - Transverse myelitis

UR - http://www.scopus.com/inward/record.url?scp=84880831388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880831388&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2013.05.005

DO - 10.1016/j.jneuroim.2013.05.005

M3 - Article

C2 - 23768728

AN - SCOPUS:84880831388

SN - 0165-5728

VL - 261

SP - 120

EP - 122

JO - Advances in Neuroimmunology

JF - Advances in Neuroimmunology

IS - 1-2

ER -

Patients with transverse myelitis who developed venous thromboembolism while hospitalized have increased rate for inpatient mortality

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this